Lack of response of severe steroid-dependent chronic urticaria to rituximab [12]

Clinical and Experimental Dermatology

Volumn 32, Issue 3, 2007, Pages 333-334

  Mallipeddi, R ^a   Grattan, C E H ^a  

^a ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMITRIPTYLINE; AZATHIOPRINE; COLCHICINE; CORTICOSTEROID; CYCLOSPORIN A; DANAZOL; DAPSONE; DOXEPIN; FLUOXETINE; HYDROXYCHLOROQUINE; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MONTELUKAST; RITUXIMAB; SALAZOSULFAPYRIDINE; STEROID;

ADULT; CASE REPORT; CLINICAL TRIAL; DISEASE SEVERITY; DRUG DEPENDENCE; FOLLICULAR LYMPHOMA; HELICOBACTER INFECTION; HELICOBACTER PYLORI; HORMONE DEPENDENCE; HUMAN; LETTER; MALE; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SKIN BIOPSY; URTICARIA;

ADULT; ANTIBODIES, MONOCLONAL; HUMANS; MALE; STEROIDS; TREATMENT FAILURE; URTICARIA;

EID: 33947700338     PISSN: 03076938     EISSN: 13652230     Source Type: Journal    
DOI: 10.1111/j.1365-2230.2007.02365.x     Document Type: Letter

References (4)

1. Greaves M. Chronic urticaria. J Allergy Clin Immunol 2000; 105: 664-72.
2. Chiappetta N, Steier J, Gruber B. Rituximab in the treatment of refractory dermatomyositis. J Clin Rheumatol 2005; 11: 264-6.
3. Arin MJ, Engert A, Krieg T et al. Anti-CD20 monoclonal antibody (rituximab) in the treatment of pemphigus. Br J Dermatol 2005; 153: 620-5.
4. Saigal K, Valencia IC, Cohen J et al. Hypocomplementemic urticarial vasculitis with angioedema, a rare presentation of systemic lupus erythematosus: rapid response to rituximab. J Am Acad Dermatol 2003; 49: S283-S285.